Company
BeyondSpring Pharmaceuticals
Transforming cancer care with immune-modulating therapies
Also known as BeyondSpring
- Status
- IPOas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Florham Park, NJ, United States
- Founded
- 2010
- beyondspringpharma.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At BeyondSpring, we are committed to raising the standard of care for cancer patients with first-in-class treatments that improve the lives and clinical outcomes for millions of patients in need.
Funding snapshot
- Total raised
- $7.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $7.2M2017-03-14
Funding rounds
- Round, 2017
- $7.2M2017-03-14, SEC form D sold, 1 investor
About the company
- Status notes
- BeyondSpring Inc. (NASDAQ: BYSI)
Products
- Other
- Plinabulin
Loading relationship preview